Purpose: The hematuria-dysuria syndrome is the most common reported complic
ation of gastrocystoplasty. We reviewed our cases of gastrocystoplasty to d
etermine the long-term incidence and significance of the syndrome.
Materials and Methods: We performed a retrospective study of 78 patients wh
o underwent gastrocystoplasty at our institution between July 1989 and Octo
ber 1994. A total of 72 of the 78 cases were evaluated within the last year
to elicit symptoms of the hematuria-dysuria syndrome.
Results: Spina bifida and bladder exstrophy were the most common diagnoses
of patients undergoing gastrocystoplasty. There were 3 (4%) patients who re
quired medications on a continuous basis to control symptoms of the hematur
ia-dysuria syndrome. However, using broad criteria 17 (24%) patients would
be categorized as having the syndrome. Of these patients 9 did not require
any medications and 4 occasionally took medications to control symptoms. A
significant increase in the incidence of the hematuria-dysuria syndrome was
detected in those cases with a sensate compared to those with an insensate
urethra.
Conclusions: The hematuria-dysuria syndrome is a clinically significant pro
blem at long-term followup in a small percentage of patients treated with g
astrocystoplasty. The lowest incidence is in those children with an insensa
te urethra who are continent. When symptoms occur they are easily treated i
n the majority of cases. We believe that gastrocystoplasty remains a viable
option in the armamentarium of bladder augmentation.